BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 34204265)

  • 1. Soluble Cytoplasmic Expression and Purification of Immunotoxin HER2(scFv)-PE24B as a Maltose Binding Protein Fusion.
    Park S; Nguyen MQ; Ta HKK; Nguyen MT; Lee G; Kim CJ; Jang YJ; Choe H
    Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34204265
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generation of Potent Anti-HER1/2 Immunotoxins by Protein Ligation Using Split Inteins.
    Pirzer T; Becher KS; Rieker M; Meckel T; Mootz HD; Kolmar H
    ACS Chem Biol; 2018 Aug; 13(8):2058-2066. PubMed ID: 29920062
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modular Conjugation of a Potent Anti-HER2 Immunotoxin Using Coassociating Peptides.
    Stoessel A; Groysbeck N; Guyot L; Barret L; Nominé Y; Nguekeu-Zebaze L; Bender A; Voilquin L; Lutz T; Pallaoro N; Blocat M; Deville C; Masson M; Zuber G; Chatton B; Donzeau M
    Bioconjug Chem; 2020 Oct; 31(10):2421-2430. PubMed ID: 32996763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel Anti-Mesothelin Nanobodies and Recombinant Immunotoxins with
    Nguyen MQ; Kim DH; Shim HJ; Ta HKK; Vu TL; Nguyen TKO; Lim JC; Choe H
    Mol Cells; 2023 Dec; 46(12):764-777. PubMed ID: 38052492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systematic comparison of single-chain Fv antibody-fusion toxin constructs containing Pseudomonas Exotoxin A or saporin produced in different microbial expression systems.
    Della Cristina P; Castagna M; Lombardi A; Barison E; Tagliabue G; Ceriotti A; Koutris I; Di Leandro L; Giansanti F; Vago R; Ippoliti R; Flavell SU; Flavell DJ; Colombatti M; Fabbrini MS
    Microb Cell Fact; 2015 Feb; 14():19. PubMed ID: 25889802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel recombinant anti-HER2/neu immunotoxin: design and antitumor efficiency.
    Sokolova EA; Zdobnova TA; Stremovskiy OA; Balalaeva IV; Deyev SM
    Biochemistry (Mosc); 2014 Dec; 79(12):1376-81. PubMed ID: 25716732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design and construction of scFv-PE35KDEL as a novel immunotoxin against human epidermal growth factor receptor 2 for cancer therapy.
    Shariaty Vaziri Z; Shafiee F; Akbari V
    Biotechnol Lett; 2023 Apr; 45(4):537-550. PubMed ID: 36807722
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression and purification of recombinant immunotoxin--a fusion protein stabilizes a single-chain Fv (scFv) in denaturing condition.
    Kim SH
    Protein Expr Purif; 2003 Jan; 27(1):85-9. PubMed ID: 12509988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Affitoxin--a novel recombinant, HER2-specific, anticancer agent for targeted therapy of HER2-positive tumors.
    Zielinski R; Lyakhov I; Jacobs A; Chertov O; Kramer-Marek G; Francella N; Stephen A; Fisher R; Blumenthal R; Capala J
    J Immunother; 2009 Oct; 32(8):817-25. PubMed ID: 19752752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A chemical conjugate between HER2-targeting antibody fragment and Pseudomonas exotoxin A fragment demonstrates cytotoxic effects on HER2-expressing breast cancer cells.
    Lee S; Park S; Nguyen MT; Lee E; Kim J; Baek S; Kim CJ; Jang YJ; Choe H
    BMB Rep; 2019 Aug; 52(8):496-501. PubMed ID: 30670149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Soluble expression of recombinant immunotoxin against human bladder carcinoma and its anti-tumor activity].
    Chao K; He D; Yang H; Zhang Z; Lin Q; Guo AG; Huang HL
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2004 Sep; 20(5):568-71. PubMed ID: 15367349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Breast cancer targeted/ therapeutic with double and triple fusion Immunotoxins.
    Goleij Z; Mahmoodzadeh Hosseini H; Sedighian H; Behzadi E; Halabian R; Sorouri R; Imani Fooladi AA
    J Steroid Biochem Mol Biol; 2020 Jun; 200():105651. PubMed ID: 32147458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Studies of the expression, purification, renaturation and biologic activity of an anti-CEA immunotoxin].
    Yang H; He D; Chao K; Lin Q; You S; Huang HL
    Sheng Wu Gong Cheng Xue Bao; 2004 May; 20(3):348-51. PubMed ID: 15971603
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Construction and in vitro evaluation of RFT5(scFv)-ETA', a new recombinant single-chain immunotoxin with specific cytotoxicity toward CD25+ Hodgkin-derived cell lines.
    Barth S; Huhn M; Wels W; Diehl V; Engert A
    Int J Mol Med; 1998 Jan; 1(1):249-56. PubMed ID: 9852227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression, purification, and characterization of an immunotoxin containing a humanized anti-CD25 single-chain fragment variable antibody fused to a modified truncated Pseudomonas exotoxin A.
    Wang H; Dai J; Li B; Fan K; Peng L; Zhang D; Cao Z; Qian W; Wang H; Zhao J; Guo Y
    Protein Expr Purif; 2008 Mar; 58(1):140-7. PubMed ID: 17950620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of VGRNb-PE immunotoxin in transplastomic lettuce (Lactuca sativa L.).
    Mirzaee M; Jalali-Javaran M; Moieni A; Zeinali S; Behdani M
    Plant Mol Biol; 2018 May; 97(1-2):103-112. PubMed ID: 29633168
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular construction and characterization of a novel exotoxin fusion protein that selectively blocks the B7:CD28 costimulatory signal system.
    Xi Y; Yuan Z; Zhang H; Guan H; Kong F; Liu N; Liang F; Cui J; Guo S; Sun Y; Xi C
    J Immunother; 2006; 29(6):586-95. PubMed ID: 17063121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Target-specific cytotoxic effects on HER2-expressing cells by the tripartite fusion toxin ZHER2:2891-ABD-PE38X8, including a targeting affibody molecule and a half-life extension domain.
    Liu H; Seijsing J; Frejd FY; Tolmachev V; Gräslund T
    Int J Oncol; 2015 Aug; 47(2):601-9. PubMed ID: 26046132
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recombinant immunotoxins containing the VH or VL domain of monoclonal antibody B3 fused to Pseudomonas exotoxin.
    Brinkmann U; Lee BK; Pastan I
    J Immunol; 1993 Apr; 150(7):2774-82. PubMed ID: 8454854
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An anti-GD2 single chain Fv selected by phage display and fused to Pseudomonas exotoxin A develops specific cytotoxic activity against neuroblastoma derived cell lines.
    Tur MK; Sasse S; Stöcker M; Djabelkhir K; Huhn M; Matthey B; Gottstein C; Pfitzner T; Engert A; Barth S
    Int J Mol Med; 2001 Nov; 8(5):579-84. PubMed ID: 11605031
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.